SUZ12 is involved in progression of non-small cell lung cancer by promoting cell proliferation and metastasis. (Q54368172)

28 May 2018

title

SUZ12 is involved in progression of non-small cell lung cancer by promoting cell proliferation and metastasis. (English)

1 reference

28 May 2018

author name string

Chunhua Liu

1

1 reference

28 May 2018

Xuefei Shi

2

1 reference

28 May 2018

Li Wang

3

1 reference

28 May 2018

Ying Wu

4

1 reference

28 May 2018

Feiyan Jin

5

1 reference

28 May 2018

Cuiqing Bai

6

1 reference

28 May 2018

Yong Song

7

1 reference

28 May 2018

publication date

15 March 2014

1 reference

28 May 2018

published in

Tumor Biology

1 reference

28 May 2018

volume

35

1 reference

28 May 2018

page(s)

6073-6082

1 reference

28 May 2018

issue

6

1 reference

28 May 2018

https://scigraph.springernature.com/pub.10.1007/s13277-014-1804-5

exact match

0 references

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

21 January 2018

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Integrated molecular portrait of non-small cell lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Polycomb complexes repress developmental regulators in murine embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Role of histone H3 lysine 27 methylation in Polycomb-group silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

EZH2 and histone 3 trimethyl lysine 27 associated with Il4 and Il13 gene silencing in Th1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

The Polycomb group protein EZH2 directly controls DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Polycomb complex 2 is required for E-cadherin repression by the Snail1 transcription factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Role of the polycomb repressive complex 2 in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

EZH2 promotes proliferation and invasiveness of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

The polycomb group protein EZH2 is involved in progression of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

SUZ12 promotes human epithelial ovarian cancer by suppressing apoptosis via silencing HRK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Deregulated expression of the polycomb-group protein SUZ12 target genes characterizes mantle cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

An E2F1-dependent gene expression program that determines the balance between proliferation and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Suz12 binds to silenced regions of the genome in a cell-type-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

E2F-1 overexpression correlates with decreased proliferation and better prognosis in adenocarcinomas of Barrett oesophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Impact of E2F-1 expression on clinical outcome of gastric adenocarcinoma patients with adjuvant chemoradiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Hypoxia-inducible factors mediate coordinated RhoA-ROCK1 expression and signaling in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

MicroRNA 135a suppresses lymph node metastasis through down-regulation of ROCK1 in early gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

The effect of ROCK-1 activity change on the adhesive and invasive ability of Y79 retinoblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Hyaluronan stimulates transformation of androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Activating ROCK1 somatic mutations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Neuronal repellent Slit2 inhibits dendritic cell migration and the development of immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Regulation of axon guidance by slit and netrin signaling in the Drosophila ventral nerve cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Regulation of commissural axon pathfinding by slit and its Robo receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Roundabout controls axon crossing of the CNS midline and defines a novel subfamily of evolutionarily conserved guidance receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Slit-2 induces a tumor-suppressive effect by regulating beta-catenin in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

Relative Abundance of EGFR Mutations Predicts Benefit From Gefitinib Treatment for Advanced Non–Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1804-5

E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer

21 January 2018

1 reference

12 December 2020

Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue.

1 reference

12 December 2020

Expression of the E2F family in human gastrointestinal carcinomas

1 reference

12 December 2020

The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer

1 reference

12 December 2020

Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterization

1 reference

12 December 2020

Non-small cell lung cancer--genetic predictors

1 reference

12 December 2020

ROCK has a crucial role in regulating prostate tumor growth through interaction with c-Myc

1 reference

12 December 2020

Deletions in chromosome 4 differentially associated with the development of cervical cancer: evidence of slit2 as a candidate tumor suppressor gene

1 reference

12 December 2020

Clinical trials and biomarker research on lung cancer in China

1 reference

12 December 2020

E2F-1: a proliferative marker of breast neoplasia

1 reference

12 December 2020

Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions

1 reference

12 December 2020

10.1007/S13277-014-1804-5

Identifiers

DOI

1 reference

28 May 2018

release_yliuh3a75vcsjfanly5nrbpjiq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yliuh3a75vcsjfanly5nrbpjiq

24 November 2022

mapped directly with Wikidata item

PubMed ID

24633887

1 reference

28 May 2018